-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C6J/J79lAKCfrWGtiWkl0pjcPXjBQae4yLc+lp7GFozfs3kyomkgWLUWlHNL4zsL ietHNGNpw+8Eu78jjpvdQA== 0000908662-07-000340.txt : 20070928 0000908662-07-000340.hdr.sgml : 20070928 20070928125642 ACCESSION NUMBER: 0000908662-07-000340 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070806 FILED AS OF DATE: 20070928 DATE AS OF CHANGE: 20070928 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHCARE ACQUISITION CORP CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2116 FINANCIAL CENTER STREET 2: 666 WALNUT STREET CITY: DES MOINES STATE: IA ZIP: 50309 BUSINESS PHONE: 515-244-5746 MAIL ADDRESS: STREET 1: 2116 FINANCIAL CENTER STREET 2: 666 WALNUT STREET CITY: DES MOINES STATE: IA ZIP: 50309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CZEREPAK ELIZABETH CENTRAL INDEX KEY: 0001263500 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 071141521 BUSINESS ADDRESS: BUSINESS PHONE: 301 944 6600 MAIL ADDRESS: STREET 1: 20425 SENECA MEADOWS PARKWAY CITY: GERMANTOWN STATE: MD ZIP: 20876 3/A 1 edgar.xml PRIMARY DOCUMENT X0202 3/A 2007-08-06 2007-08-08 0 0001326190 HEALTHCARE ACQUISITION CORP PIP 0001263500 CZEREPAK ELIZABETH C/O BEAR STEARNS HEALTH INNOVENTURES, LP 237 PARK AVENUE, 7TH FLOOR NEW YORK NY 10017 1 0 0 0 Common Stock 1320087 I Held by Bear Stearns Health Innoventures Group 8% Convertible Notes 10.00 2007-08-03 2009-08-03 Common Stock 254106 I Held by Bear Stearns Health Innoventures Group Stock Option (right to buy) 4.22 2007-08-03 2016-01-18 Common Stock 1104 I Held by Bear Stearns Health Innoventures Group Received in connection with the merger of PharmAthene, Inc. with a wholly-owned subsidiary of Healthcare Acquisition Corp. (the "Merger") on August 3, 2007, after which Healthcare Acquisition Corp. changed its name to PharmAthene, Inc. Elizabeth Czerepak was appointed to the Board as of August 6, 2007. This amendment reflects the final consideration received in the Merger, including adjustments. Elizabeth Czerepak is a managing partner of Bear Stearns Innoventures Management, LLC ("Management"). Management is the sole general partner of Bear Stearns Health Innoventures, L.P. ("BSHI"), Bear Stearns Health Innoventures Offshore, L.P. ("Offshore"), BX, L.P. ("BX"), and Bear Stearns Health Innoventures Employee Fund, L.P. ("Employee Fund"), and BSHI Members, LLC ("Members") co-invests with these funds. The securities reported are directly owned by Members, BSHI, Offshore, BX, and Employee Fund. The Reporting Person disclaims beneficial ownership of these securitries except to the extent of her proportionate pecuniary interest therein. Represents $2,541,079 principal amount of converitble notes received in connection with the Merger in exchange for existing convertible notes of PharmAthene, Inc., the acquired company. Represents existing stock options of PharmAthene, Inc., the acquired company, that were assumed in the Merger. Options vest in 25% annual increments beginning January 18, 2007. /s/ Elizabeth Czerepak 2007-09-27 -----END PRIVACY-ENHANCED MESSAGE-----